Home

 

LEADING ALZHEIMER'S RESEARCHER TALKS ABOUT LITHIUM ALTERNATIVE

AULT LIFE SCIENCES WORKING WITH UNIVERSITIES

Ault Life Sciences

OUR APPROACH

Ault Life Sciences invests in disruptive technologies and processes in the biotechnology and health care sectors. Although our structure may be corporate, our approach with our stakeholders is one of partnership. Our proactive value-added investment approach combined with our team’s diligence and expertise has us strategically positioned for explosive growth in the near future.

Ault Life Sciences

OUR MISSION

Disciplined focus on neuro-degenerative diseases and the biotechnology sector where Ault Life Sciences expertise can drive exponential growth.

In my 30 years on Wall Street, I have come to understand the risks and rewards associated with investing in innovative life science companies. Having benefited from numerous successful transactions in this sector, I have now created a new venture, Ault Life Sciences. This was done to both support a promising new company (Alzamend Neuro) in advancing two treatments for Alzheimer’s disease and to uncover additional promising companies and technologies with a focus on treating neuro-degenerative diseases. Our leadership team and network of scientific experts are in position as we look to capture the tremendous upside potential of the life sciences sector.
Todd Ault, Founder of Ault Life Sciences
Portfolio

Investment Portfolio

News & Press

Alzamend News

Scroll to top